Work

PCR33 Bimekizumab Led to Sustained Improvements in Health-Related Quality of Life and Work Productivity in Patients With Axial Spondyloarthritis: 3-Year Results From Two Phase 3 Studies

Year: 2025

Type: conference-abstract

Source: Value in Health

DOI: 10.1016/j.jval.2025.09.2506

Authors: Elena Nikiphorou, Martin Rudwaleit, Mark Hwang, Pedro M. Machado, Atul Deodhar, Maureen Dubreuil, Sarah Kavanagh, Vanessa Taieb, Christine De La Loge, Michael Frank Mørup, Annelies Boonen

Institutions: King's College London, King's College Hospital, Bielefeld University, Klinikum Bielefeld, The University of Texas Health Science Center at Houston, University College London Hospitals NHS Foundation Trust, London North West Healthcare NHS Trust, Northwick Park Hospital, Oregon Health & Science University, Boston University, UCB Pharma (France), Maastricht University Medical Centre, Maastricht University, Care and Public Health Research Institute

Language: English

Topic: Spondyloarthritis Studies and Treatments

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417482078

Cites:

Cited by:

Related to: